Antibe Therapeutics Price Patterns
| ATBPFDelisted Stock | USD 0.22 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Antibe Therapeutics hype-based prediction, you can estimate the value of Antibe Therapeutics from the perspective of Antibe Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Antibe Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Antibe because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Antibe Therapeutics after-hype prediction price | USD 0.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Antibe |
Antibe Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Antibe Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Antibe Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Antibe Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Antibe Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Antibe Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Antibe Therapeutics' historical news coverage. Antibe Therapeutics' after-hype downside and upside margins for the prediction period are 0.22 and 0.22, respectively. We have considered Antibe Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Antibe Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Antibe Therapeutics is based on 3 months time horizon.
Antibe Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Antibe Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Antibe Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Antibe Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.22 | 0.22 | 0.00 |
|
Antibe Therapeutics Hype Timeline
Antibe Therapeutics is presently traded for 0.22. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Antibe is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Antibe Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.22. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. Antibe Therapeutics recorded a loss per share of 0.41. The entity last dividend was issued on the 1st of December 2020. The firm had 1:10 split on the 1st of December 2020. Assuming the 90 days horizon the next projected press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.Antibe Therapeutics Related Hype Analysis
Having access to credible news sources related to Antibe Therapeutics' direct competition is more important than ever and may enhance your ability to predict Antibe Therapeutics' future price movements. Getting to know how Antibe Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Antibe Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LXXGF | Lexagene Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TMDIF | Titan Medical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VRCDF | Verici Dx plc | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 60.53 | |
| CNPOF | RIV Capital | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EIGRQ | Eiger BioPharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LVCLY | Living Cell Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RXMD | Progressive Care | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MGCLF | MGC Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRVFF | Nuvo Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CDXFF | Cloud DX | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Antibe Therapeutics Additional Predictive Modules
Most predictive techniques to examine Antibe price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Antibe using various technical indicators. When you analyze Antibe charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Antibe Therapeutics Predictive Indicators
The successful prediction of Antibe Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Antibe Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Antibe Therapeutics based on analysis of Antibe Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Antibe Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Antibe Therapeutics's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Antibe Pink Sheet
If you are still planning to invest in Antibe Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antibe Therapeutics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |